Peritoneal Carcinomatosis
📧 Sign up to get email alerts when something new happens for Peritoneal Carcinomatosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis [Phase 2]
This Phase 2 clinical trial assesses sequential systemic therapy followed by intraperitoneal paclitaxel for gastric cancer with peritoneal c…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis [Phase 1]
A Phase 1 trial evaluating intraperitoneal paclitaxel in combination with the NALIRIFOX regimen for pancreatic ductal adenocarcinoma with pe…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis [NA]
Ongoing recruitment for a study evaluating whether cardiac coherence can reduce anxiety in patients operated for peritoneal carcinomatosis (…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and Irinotecan [Phase 1, Phase 2]
This trial update reports completion of a Phase 1/Phase 2 study evaluating cytoreductive surgery followed by hyperthermic intraperitoneal ch…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis [Phase 2]
Phase 2 clinical trial investigating hyperthermic intraperitoneal chemotherapy (HIPEC) for metastatic pancreatic cancer with peritoneal meta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer [Phase 1]
Clinical trial update indicating a Phase 1 study of PIPAC (pressurized intraperitoneal aerosol chemotherapy) to treat peritoneal carcinomato…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial [Phase 3]
A Phase 3 study of pressurized intraperitoneal aerosolized chemotherapy with mitomycin for unresectable appendiceal or colorectal cancer wit…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: PONDER: Pelvic Peritonectomy in Early Stage Ovarian Tumors [NA]
The PONDER trial is studying pelvic peritonectomy for early-stage ovarian tumors with peritoneal carcinomatosis. The study status is NOT_YET…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology [Phase 2]
A Phase II clinical trial evaluating perioperative paclitaxel in patients with gastric adenocarcinoma and peritoneal carcinomatosis or posit…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer [Phase 2]
A Phase II clinical trial is evaluating laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer, with rec…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma [Phase 2]
Phase 2 clinical trial evaluating surgery with heated intraperitoneal chemotherapy for adrenocortical carcinoma with peritoneal carcinomatos…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer [NA]
A completed clinical trial evaluated the combination of PIPAC and FOLFOX for gastric cancer with peritoneal carcinomatosis.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer [Phase 1]
Phase 1 clinical trial evaluating biweekly intraperitoneal oxaliplatin with systemic capecitabine and bevacizumab for peritoneal carcinomato…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC [Phase 1, Phase 2]
Update on a Phase 1/2 trial of Radspherin in colorectal cancer patients with peritoneal carcinomatosis treated with HIPEC.
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis [NA]
This ClinicalTrials.gov entry describes a recruiting study to develop a patient-derived vascularized microtumor model of gastrointestinal pe…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Bonds Between Circulating Tumoral ADN (ctDNA) and the Development of Peritoneal Carcinomatosis for Patients Under PIPAC [NA]
A completed clinical trial investigating the relationship between circulating tumor DNA and the development of peritoneal carcinomatosis in …
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination. [Phase 3]
A Phase 3 clinical trial evaluating gastrectomy with cytoreductive surgery and HIPEC for gastric cancer with peritoneal dissemination is cur…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer [Phase 1]
Phase 1 trial evaluating intraperitoneal aerosolized nanoliposomal irinotecan (Nal-IRI) for peritoneal carcinomatosis from gastrointestinal …
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: MT027 Cell Injection in Patients With Advanced Primary or Secondary Peritoneal Tumors [NA]
This clinical trial update describes MT027 cell injection being studied in patients with advanced primary or secondary peritoneal tumors. Th…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
The clinical trial evaluating postoperative chemotherapy for high-grade appendiceal adenocarcinoma with peritoneal carcinomatosis was termin…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer
This clinical trial aims to predict response to hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric and colon cancers with peritone…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis [Phase 1]
Phase 1 study evaluating nivolumab with or without ipilimumab in patients with recurrent or high-grade gynecologic cancers and metastatic pe…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors [Phase 1]
MT027 is being studied in a Phase 1 trial for patients with B7-H3-positive advanced malignant solid tumors, including primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated GL-ONC1, an oncolytic vaccinia virus, in patients with advanced peritoneal carcinomatosis.
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial evaluating Tirellizumab combined with oral, IV, and intraperitoneal chemotherapy for gastric/gastroesophageal junction/esophag…